On April 12, 2023 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) reported that the company will present at the following investor conferences (Press release, BioCryst Pharmaceuticals, APR 12, 2023, View Source [SID1234629987]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19th at 8:45 a.m. ET

The BofA Securities 2023 Health Care Conference in Las Vegas on Wednesday, May 10th at 6:00 p.m. ET

The JMP Securities Life Sciences Conference in New York on Tuesday, May 16th at 2:30 p.m. ET

The RBC Capital Markets Global Healthcare Conference in New York on Wednesday, May 17th at 8:00 a.m. ET

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.